NAAG (N-acetylaspartylglutamate) is an abundant neuropeptide in the vertebrate nervous system. It is released from synaptic terminals in a calcium-dependent manner and has been shown to act as an agonist at the type II metabotropic glutamate receptor mGluR3. It has been proposed that NAAG may also be released from axons. So far, however, it has remained unclear how NAAG is transported into synaptic or other vesicles before it is secreted. In the present study, we demonstrate that uptake of NAAG and the related peptide NAAG 2 (N-acetylaspartylglutamylglutamate) into vesicles depends on the sialic acid transporter sialin (SLC17A5). This was demonstrated using cell lines expressing a cell surface variant of sialin and by functional reconstitution of sialin in liposomes. NAAG uptake into sialin-containing proteoliposomes was detectable in the presence of an active H + -ATPase or valinomycin, indicating that transport is driven by membrane potential rather than H + gradient. We also show that sialin is most probably the major and possibly only vesicular transporter for NAAG and NAAG 2 , because ATP-dependent transport of both peptides was not detectable in vesicles isolated from sialindeficient mice.
INTRODUCTION
The dipeptide NAAG (N-acetylaspartylglutamate) is present at high micromolar to low millimolar concentrations in the mammalian nervous system [1] . NAAG is mainly synthesized in neurons and is calcium-dependently released from synaptic vesicles on depolarization [2] [3] [4] [5] . NAAG appears to be a cotransmitter at glutamatergic and GABAergic synapses [6] , but was also found in cholinergic, noradrenergic and serotonergic neurons in the central nervous system [7] . It was proposed that NAAG may also be released from axons and could be an important source of NAA (N-acetylaspartate) in white matter [8] . Several studies showed that specific inhibitors of the NAAG-degrading enzyme GCP-II (glutamate carboxypeptidase II) and NAAG itself are neuroprotective [9] [10] [11] . This appears to be mediated via activation of the type II mGluR3 (metabotropic glutamate receptor 3) [12] that is localized on presynaptic membranes and astrocytes [1, 13] . The specific agonist activity of NAAG at mGluR3 has been demonstrated in vitro and in vivo in many reports (for an overview see [14] ). Under some experimental conditions, however, NAAG failed to activate signal transduction via mGluR3 [15] . Owing to the large amount of water molecules bound by NAAG, it may also function, together with its precursor NAA, as a molecular water pump [16] , which is important because neurons do not express significant amounts of aquaporins or other water channels [16, 17] .
Changes in NAAG levels have been found in schizophrenia patients [18] . Strongly elevated NAAG levels in CSF (cerebrospinal fluid) have been observed in some leukodystrophies, including PMD (Pelizaeus-Merzbacher disease), PMD-like disease and SD [Salla disease; caused by mutations in the sialin (also referred to as SLC17A5) gene, encoding the lysosomal sialic acid transporter] [19] [20] [21] [22] . In most leukodystrophies examined, however, NAAG levels are not increased [20] . The reason for these specific changes in a small group of leukodystrophies and their role in the pathogenesis of these diseases is unknown.
NAAG is synthesized from NAA and glutamate by cytosolic NAAGSs (NAAG synthetases) [1] . Two structurally related NAAGSs (NAAGS-I and NAAGS-II, encoded by the genes Rimklb and Rimkla respectively) have been previously identified [23] [24] [25] . Both enzymes can also catalyse the synthesis of β-citrylglutamate [24] . In addition, NAAGS-II synthesizes the tripeptide NAAG 2 (N-acetylaspartylglutamylglutamate), which we identified in the mouse brain [25] . The physiological role of NAAG 2 is currently unknown.
Although the presence of NAAG in synaptic vesicles was documented some decades ago [3] , it is unknown how NAAG is taken up by synaptic vesicles, other vesicles, or whether it can also be transported directly through the plasma membrane. In the present study, we demonstrate ATP-dependent NAAG transport into vesicle preparations containing synaptic vesicles. In addition, we show that uptake of NAAG, and the related peptide NAAG 2 , into these vesicles is catalysed by the sialic acid transporter sialin.
EXPERIMENTAL
Isotope-labelled amino acids and peptides [1- 14 C]Acetyl-Asp-Glu-OH (2.8 mCi/mmol) and [1-14 C]acetylAsp-Glu-Glu-OH (4.2 mCi/mmol) were both obtained from Hartmann Analytic. For some experiments, [ 14 C]NAAG was synthesized by N-acetylation of Asp-Glu using 14 C-labelled acetic anhydride (55 mCi/mmol; Hartmann Analytic). [6- 3 H]Neu5Ac (N-acetylneuraminic acid) (20 Ci/mmol) was purchased from Hartmann Analytic. [ 14 C]Glutamate (260 mCi/mmol) was
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Plasmids
A human sialin (SLC17A5) cDNA (clone IRAT p970 H0614D) was purchased from Source BioScience. The sialin coding region was amplified by PCR with Phusion ® DNA-Polymerase (New England Biolabs), using the oligonucleotides shown in Table 1 . PCR products were digested with the appropriate restriction endonucleases and ligated into pEGFP-C3 (Clontech). Sitedirected mutagenesis was carried out by PCR with Phusion ® DNA-Polymerase using the oligonucleotides shown in Table 1 . All DNA constructs were confirmed by DNA sequencing.
Western blotting
SDS/PAGE and Western blotting using chemiluminescence detection were carried out as described in [27] . The following primary antibodies were used: rabbit anti-GFP (Abcam), mouse anti-synaptophysin (Merck), mouse anti-Na + /K + -ATPase (Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, Iowa, U.S.A.) and goat anti-EEA-1 (early endosome antigen 1; Santa Cruz Biotechnology) antibodies. Secondary antibodies were horseradish peroxidase-conjugated goat antimouse, goat anti-rabbit (Dianova) and donkey anti-goat (Merck) sera.
Cell culture and transfection
HEK (human embryonic kidney)-293T cells were maintained in DMEM (Dulbecco's modified Eagle's medium)-GlutaMax (Invitrogen) supplemented with 10 % FBS, penicillin (100 units/ml) and streptomycin (100 μg/ml). Cells were transfected using the calcium phosphate method [28] .
HPLC and ESI-MS (electrospray ionization tandem MS) analysis
Quantification of NAA, NAAG and NAAG 2 was done by HPLC/ESI-MS, as described in [24] using internal 13 C-labelled standards (see above). Frozen brain tissues of 2-3-week-old sialin-deficient mice and wild-type littermates were analysed. Standards (50 or 70 nmol) were added to 50-70 μl of brain peptide (methanol) extract, and 10 μl of each sample were directly injected into HPLC. CSF (2 μl), diluted in a ratio of 1:5 with water, was directly injected into HPLC with 20 nmol standards. ESI-MS spectra (ESI-MS HCTultra, Bruker Daltonics) were recorded in negative ion mode with Auto/MS fragmentation. Eluate fractions from the HPLC were directly injected. The amounts of NAAG, NAAG 2 and NAA were determined using the intensities of the internal standard in the defined timeframe of each peptide. The signals were controlled by fragmentation of the peptide mass peaks in each measurement.
Isolation of vesicles
Fractions from mouse brain that contain synaptic vesicles and other microvesicles were prepared as described by Hell et al. [29, 30] , except that the controlled pore glass bead chromatography step was omitted. Mouse brain (5 g) was used for each preparation from 2-3-week-old sialin-deficient mice and wild-type littermates, or 4-6-week-old C57BL/6J mice. After homogenization of the brain tissue in 0.32 M sucrose, 10 mM Hepes/KOH (pH 7.3), 0.5 μg/ml pepstatin A and 1 μg/ml leupetin, a crude vesicle containing supernatant was prepared by centrifugation at 47 000 g for 10 min followed by centrifugation at 120 000 g for 40 min. The supernatant was layered on a sucrose gradient and centrifuged at 250 000 g for 120 min. After resuspending the pellet in 0.32 M sucrose, 10 mM Hepes/KOH (pH 7.3), insoluble and soluble fractions were separated by centrifugation at 27 000 g for 10 min. The yield of vesicles was approximately 2-3 mg of protein for each preparation.
Vesicular NAAG transport assay
The vesicle-containing fraction was diluted in standard assay buffer (230 mM sucrose, 4 mM KCl and 10 mM Hepes/KOH, pH 7.3) to a protein concentration of 1 mg/ml. Aliquots (100 μl) were preincubated for 5 min at 32
• C. After 10 min at 32 • C, the reaction was stopped by adding 1 ml of ice-cold standard assay buffer followed by immediate filtration through nitrocellulose filters (0.45 μm pore size; Whatman). Filters were washed with 12 ml of ice-cold standard assay buffer and bound radioactivity was determined by liquid scintillation counting. In control experiments ATP was omitted or the vesicles were incubated on ice with radiolabelled substrates for 10 s.
Cellular NAAG transport assay
HEK-293T cells in six-well plates were transfected with the empty vector (pEGFP-C3), EGFP-tagged wild-type SLC17A5 or the sialin mutant L22A/L23A. At 24 h after transfection, cells were washed with Krebs-Ringer solution with low K + [120 mM NaCl, 4.7 mM KCl, 2.2 mM CaCl 2 , 1.2 mM MgCl 2 and 0.18 % glucose containing 10 mM Hepes (pH 7.0), 10 mM glycylglycine (pH 9.0) or 10 mM MES (pH 5.5)] or Krebs-Ringer solution with high K + [120 mM KCl, 4.7 mM NaCl, 2.2 mM CaCl 2 , 1.2 mM MgCl 2 and 0.18 % glucose containing 10 mM Hepes (pH 7.0), 10 mM glycylglycine (pH 9.0) or 10 mM MES (pH 5.5)]. Cells were then preincubated in the same buffer for 15 min. NAAG transport was initiated by adding [
14 C]NAAG (50-70 nmol per well) and the cells were incubated for 45 min at 37
• C. The transport was stopped by washing the cells five times with Krebs-Ringer solution. Efficiency of the washing procedure was monitored by liquid scintillation counting and only samples with less than 60 c.p.m. in the last wash fraction were used in the experiments. Peptides were extracted with 800 μl of 90% methanol per well. The extracts were dried under vacuum, dissolved in 20 % ethanol and applied on to silica gel 60 HPTLC (high-performance TLC) plates (Merck). Chromatograms were developed in a chloroform, methanol and acetic acid mixture (9:1:5, by vol.). Radioactive signals were visualized using Bioimager screens (Fuji). For quantification, radioactive bands were scraped out, dissolved in water and measured by liquid scintillation counting. Uptake of Neu5Ac was measured by liquid scintillation counting after incubation for 45 min with 250000 c.p.m. [6- 3 H]Neu5Ac in Krebs-Ringer solution with low K + at pH 5.5, pH 7.0 or pH 9.0.
Purification of sialin and VGLUT (vesicular glutamate transporter) 2
Sialin and VGLUT2 were expressed as hexahistidine-tagged proteins using the baculovirus method in insect cells as described in [31] , except that High Five cells were used instead of Sf9 cells. For purification, solubilized proteins were incubated with HisPur Cobalt Resin (Thermo Fisher Scientific) overnight at 4 • C. The resin was washed with 10 ml of 20 mM Mops/Tris (pH 7.0), 5 mM imidazole, 20 % glycerol and 1 % octyl glucoside. Bound proteins were eluted with the same buffer containing 100 mM imidazol. The purified proteins were stored at − 80
• C. Bacterial H + -ATPase was expressed as hexahistidine-tagged protein in Escherichia coli DK8 (kindly provided by Georg Groth, University of Düsseldorf, Düsseldorf, Germany) transformed with plasmid pSK11 (kindly provided by Holger Lill, VU University, Amsterdam, The Netherlands) as described in [32, 33] . For isolation of membrane vesicles, cells were resuspended in 3 ml of 50 mM Tricine/NaOH (pH 8.0), 10 mM MgCl 2 and 10 % glycerol per gram of cells and sonicated with a tip sonifier (50 W, 30 kHz, amplitude 100; Hielscher Ultrasonics) for 5 min. The cell debris was sedimented by centrifugation for 10 min at 30 000 g at 4
• C. The supernatant was centrifuged at 287 000 g for 75 min (4
• C). The pellet (membrane vesicles) was resuspended in 20 mM Tes/NaOH (pH 7.0), 5 mM MgCl 2 , 150 mM KCl, 10 % glycerol, 0.1 mM PMSF and 0.8 % octyl glucoside, and incubated for 5 min at 37
• C, followed by 5 min at room temperature (21-23 • C) under shaking (this step was repeated once). After centrifugation at 330 000 g for 1 h at 4
• C, the pellet was treated as above, in the presence of 2 % octyl glucoside. After centrifugation at 330 000 g for 1 h at 4
• C, the supernatant containing the solubilized H + -ATPase was affinity-purified as described above for sialin and VGLUT2. The purified proteins were stored at − 80
• C.
Reconstitution in liposomes and transport assay
The reconstitution and transport assays were performed as described in [31] . After reconstitution the proteoliposomes were suspended in 20 mM Mops/Tris (pH 7.0), 100 mM potassium acetate, 4 mM KCl and 5 mM magnesium acetate. Reactions were initiated by addition of NAAG at different concentrations with a constant amount of [ 14 C]NAAG in the absence or presence of 2 mM ATP. In some experiments, valinomycin (Sigma-Aldrich) was added to a final concentration of 2 μM. In this case the proteoliposomes were diluted in 20 mM Mops/Tris (pH 7.0), 150 mM potassium acetate, 4 mM KCl and 5 mM magnesium acetate.
Isolation and analysis of CSF
CSF (5-10 μl per mouse) was isolated from 2-3-week-old sialindeficient mice or wild-type littermates through the cisterna magna using a microcapillary. CSF samples were stored at − 20
• C until analysed by ESI-MS as described above.
RESULTS

Uptake of NAAG into vesicles is inhibited by Neu5Ac
In order to examine uptake of NAAG into vesicles, a fraction enriched in microvesicles was isolated from the brains of adult mice by sucrose gradient centrifugation. A comparable preparation, called SLMVs (synaptic-like microvesicles) was used previously to measure vesicular uptake of glutamate and aspartate residues [31] . The presence of synaptic vesicles in our vesicle preparation was confirmed by Western blotting with antibody against synaptophysin. Marker proteins for plasma membranes (Na + /K + -ATPase) and endosomes (EEA1) were not detected in the vesicle fraction ( Figure 1A) . Transport of [
14 C]NAAG into these vesicle preparations was detectable by liquid scintillation counting of vesicle-bound radioactivity after 10 min of incubation at 32
• C ( Figure 1B) . The uptake depended on the presence of ATP and was blocked by the uncouplers of oxidative phosphorylation FCCP and GramD, which destroy the H + gradient ( Figure 1B) . Interestingly, NAAG transport was significantly reduced in the presence of 2.5 mM of the sialic acid Neu5Ac. To determine the K m value for NAAG transport, the concentration-dependent uptake of [ 14 C]NAAG by vesicles was measured at 1 min in the presence ( + ATP) or absence ( − ATP) of 2 mM ATP. ATP-dependent NAAG uptake was dose-dependent with a K m value of 0.78 + − 0.12 mM and a V max of 32.9 + − 11.2 nmol/mg of protein ( Figure 1C) .
A cell-surface-localized sialin mutant catalyses NAAG uptake
In order to test further the hypothesis of a sialin-mediated NAAG transport, we first set up a cell-based NAAG transport assay, before performing the time-consuming task of sialin reconstitution in liposomes or breeding sialin-deficient mice to isolate sialin-deficient synaptic vesicles. We reasoned that cellular uptake of NAAG may be detectable in cells expressing a cellsurface-localized sialin variant by increasing the extracellular pH and/or depolarizing the cells in a buffer with high K + concentration. Physiologically, the NAAG transport should be directed outward. However, other ion-or membrane potentialdependent transporters have been shown to translocate the same substrates in both directions, depending on the direction of the ion gradient [34] .
An EGFP-tagged human sialin mutant in which the two leucine residues essential for lysosomal targeting [35] were exchanged by alanine (EGFP-SiaL22A/L23A) were expressed in HEK-293T cells ( Figure 2C ). Cells were incubated with 50 nmol of [ 14 C]NAAG in a Krebs-Ringer solution with low or high K + concentration at pH 5.5, pH 7.0 or pH 9.0 (see above for details) for 45 min (this long incubation time had to be used because of weak radioactive signals at shorter times). Methanolic peptide extracts were prepared and analysed by TLC, followed by detection of the radioactive peptide with a Bioimager (Figure 2A ). NAAG bands were scraped and quantified by liquid scintillation counting ( Figure 2B ). In cells expressing the empty vector (EGFP), NAAG uptake was almost undetectable, whereas NAAG was detectable in cells expressing cell-surface-localized sialin. Importantly, at pH 9.0 in a buffer with high K + , the NAAG uptake was significantly increased compared with pH 7.0 and low K + buffer. At pH 5.0, NAAG uptake was almost undetectable. Taken together, the results suggest that NAAG can be transported by sialin and that the transport depends on pH (pH gradient) and/or ψ (membrane potential difference). As a control, the uptake of [ 3 H]Neu5Ac at different pH values was examined ( Figure 2D ). In line with previous reports [35, 36] , there was efficient uptake of Neu5Ac in EGFP-SiaL22A/L23A-expressing cells. The transport was pH-dependent with the highest rate at an extracellular pH 5.0, as expected, because sialin is a H + symporter for Neu5Ac [35] .
Sialin reconstituted in liposomes mediates transport of NAAG
To confirm that sialin is a NAAG transporter, the protein was expressed in insect cells, purified and reconstituted in liposomes, together with a bacterial H + -ATPase, as described [31] . In sialincontaining proteoliposomes, we measured the ATP-dependent uptake of NAAG ( Figure 3A) . To determine the K m value for NAAG transport, the concentration-dependent uptake of [ 14 C]NAAG by the proteoliposomes was measured at 1 min in the presence of 2 mM ATP. ATP-dependent NAAG uptake was dose-dependent with a K m value of 0.2 + − 0.1 mM and a V max value of 2234 + − 52 nmol/mg of protein per min ( Figure 3B ). To examine whether NAAG transport depends on pH or ψ, we used the K + ionophor valinomycin, in the absence of ATP, to establish a stable ψ (inside positive) through K + diffusion. Transport of NAAG was also detectable under these conditions and did not differ significantly from the H + -driven transport activity ( Figure 3C ). Thus NAAG transport is mainly driven by ψ and not pH. The ATP-dependent uptake of NAAG by sialin-containing proteoliposomes was inhibited in the presence of the oxidative phosphorylation uncoupler FCCP (20 μM) or Neu5Ac (5 mM) ( Figure 3D) . As a control, we tested the transport of NAAG and glutamate by proteoliposomes containing the vesicular glutamate carrier VGLUT2 and H + - ATPase ( Figure 3E ). As expected, transport of glutamate was ATP-dependent. In contrast, NAAG transport was undetectable, irrespective of the absence or presence of ATP.
Sialin-deficient vesicles are incapable of NAAG uptake
To prove our conclusion that sialin catalyses vesicular uptake of NAAG in vivo and to address the question of whether other transporters could mediate NAAG transport, we isolated microvesicles from 2-3-week-old sialin-deficient mice (which due to the insertion of a lacZ reporter gene lack a functional sialin protein) [37] and wild-type littermates, as described above. NAAG uptake was measured for 10 min at 32 • C. In contrast with wild-type vesicles, there was no ATP-dependent NAAG uptake by vesicles from sialin-deficient mice ( Figure 4A ). Furthermore, we found an ATP-dependent transport of the tripeptide NAAG 2 in wild-type vesicles, but again no uptake of NAAG 2 by sialindeficient vesicles ( Figure 4B ). In order to exclude the possibility that, not intact NAAG, but any degradation products (e.g. NAA), were actually transported into the wild-type vesicles, we performed control experiments, where methanolic extracts of the vesicles after incubation with [ 14 C]NAAG (or [ 14 C]glutamate as a control) were examined by HPTLC ( Figure 4C) . Those experiments confirmed uptake of intact NAAG. Taken together, data from the present study show that sialin is the major and possibly only vesicular transporter for NAAG and NAAG 2 . To confirm that the vesicles isolated from sialin-deficient mice were functional, the uptake of [ 14 C]glutamate by wild-type and sialin-deficient vesicles was measured. There was no significant difference in their glutamate transport activity ( Figure 4D ).
NAAG levels are decreased in brains of sialin-deficient mice
Elevated NAAG levels in the CSF have been observed in SD patients [21, 38] . There are no reports on altered NAAG levels in ISSD (infantile sialic acid storage disease). We examined NAAG levels in the brain and CSF of 2-3-week-old sialin-deficient mice and wild-type littermates. Owing to the strongly reduced lifespan of sialin-deficient mice, older mice could not be examined. Concentrations of NAAG in the brain were significantly reduced in sialin-deficient mice, whereas levels of NAAG 2 and NAA were not changed significantly ( Figure 5A ). However, neither NAAG nor NAA levels were significantly altered in CSF ( Figure 5B ). NAAG levels in CSF were close to the detection limit. Therefore minor differences in the CSF NAAG levels cannot be ruled out. However, we can exclude a strong increase in NAAG, which in contrast has been observed in SD patients [21, 38] . NAAG 2 levels in CSF were below the detection limit. − C t method, normalized to Ubc. Expression of NAAGS-I and NAAGS-II or Nat8L were not changed significantly. In contrast, expression of GCP-II was up-regulated approximately 2-fold in sialin-deficient mice. As expected from the severe hypomyelination observed in sialin-deficient mice, expression levels of MBP and PLP were strongly reduced. The data shown are the means + − S.D. for three independent experiments (using three independent RNA preparations for each genotype). Statistical significance was calculated using Student's t test, *P < 0.05.
Changes in NAAG concentrations in sialin-deficient brains could be the result of product inhibition of NAAGSs, e.g. by NAAG or NAAG 2 . However, changes in the expression of NAAG-synthesizing enzymes may also be a possible explanation. We therefore examined the gene expression of NAAGS-I and NAAGS-II, Nat8L (NAA synthase), and the NAAG-degrading enzyme GCP-II using quantitative real-time PCR. Although the expression of the Nat8L and NAAGSs were not significantly altered in sialin-deficient mice, GCP-II expression was up-regulated 2-fold ( Figure 5C ). MBP (myelin basic protein) and PLP (proteolipid protein) were included in these experiments: expression of these two myelin markers were strongly reduced in sialin-deficient mice, as expected from the severe hypomyelination phenotype of these mice [37] .
DISCUSSION
Sialin was initially identified as a lysosomal membrane protein required for the transport of sialic acids and glucuronic acid [39] . Mutations in the sialin gene causes two variants of free sialic acid storage disease, the milder form of SD and the more severe ISSD. The extra-lysosomal localization of sialin in neurons strongly suggested additional roles of sialin beside export of sialic acid from lysosomes [40] . Sialin is present in a subset of synaptic vesicles and was identified as an aspartate transporter in synaptic vesicles [31] . In a recent publication, however, the authors did not find evidence for a sialin-mediated transport of aspartate into synaptic vesicles using vesicles isolated from sialindeficient mice [41] . Sialin reconstituted in proteoliposomes also catalyses the uptake of glutamate residues [31] . The presence of the VGLUTs may explain the absence of a significant reduction in glutamate transport activity in sialin-deficient mice compared with wild-type controls. Sialin was also identified as a nitrate transporter in the plasma membrane of salivary gland acinar cells [42] . Taken together, these studies show that sialin exhibits two different transport mechanisms, depending on the substrate: pH-dependent (H + symport) transport of substrates towards the cytosol and ψ-dependent transport of neurotransmitters into (synaptic) vesicles.
The experiments in the present study demonstrate that ATPdependent uptake of NAAG into vesicles is sialin (SLC17A5)-dependent. We show this using three different independent approaches that supported the same conclusion: (i) cells expressing a cell-surface-localized sialin variant, but not cells transfected with the empty vector import NAAG; (ii) sialin reconstituted in proteoliposomes mediated ψ-dependent NAAG uptake; and (iii) vesicles isolated from sialin-deficient mice were incapable of ATP-dependent NAAG uptake. Although the vesicle-containing fraction used for these analyses probably contain other vesicles beside synaptic vesicles, the complete loss of ATP-dependent NAAG uptake in vesicles from sialin-deficient mice suggest that sialin may be responsible for NAAG uptake into synaptic vesicles.
The presence of NAAG in synaptic vesicles had been demonstrated using specific antibodies [3] . The NAAG-related tripeptide NAAG 2 is synthesized by NAAGS-II, but not by NAAGS-I [24] . There are currently no data on the presence of NAAG 2 in synaptic vesicles, and most likely NAAG-specific antibodies will not allow the discrimination between NAAG and NAAG 2 . We could show, however, that NAAG 2 is also transported by sialin into vesicles. Thus the results of the present study suggest that NAAG 2 may also be present in synaptic vesicles and synaptically released from NAAGS-II-expressing neurons.
Because sialin may also localize to the plasma membrane, at least in some cell types [42] , it is also possible that NAAG may be exported directly from the cytosol. Thus one may speculate that elevated NAAG levels in CSF of SD patients could be directly linked to an altered NAAG transport activity, e.g. in epithelia of the CSF-blood barrier. In the cellular transport assay, the cellsurface-localized sialin catalysed NAAG uptake to some extent also at neutral pH. Whether this reflects the potential of sialin to mediate the weak transport of NAAG into neurons and glia [43] remains to be determined. This would, however, require cell surface localization of sialin with a functional lysosomal targeting signal.
We did not observe an increase in NAAG concentration in the CSF of sialin-deficient mice. This might be because of the young age of the animals. However, owing to the complete loss of sialin, sialin-deficient mice are probably more relevant as a model for ISSD. Therefore data from the present study could also indicate that elevated NAAG levels are specific for SD and not ISSD. The observed reduced NAAG levels in total brain may be a result of product inhibition of NAAGSs, owing to the impaired export of NAAG from the cytosol, where the NAAGSs are localized [23, 25] . However, because we only measured mRNA expression and did not measure enzyme activity of NAAGSs in sialin-deficient brains, we cannot exclude the possibility that reduced NAAGS activity is responsible for reduced NAAG levels. Elevated GCP-II expression could potentially result in higher GCP-II enzyme activity. Otherwise, most NAAG is present in neurons [8] and, after release, NAAG is rapidly hydrolysed by GCP-II. It appears unlikely therefore that an increase in GCP-II activity is responsible for reduced levels of NAAG in the brains of sialin-deficient mice, where NAAG release by neurons should be strongly reduced.
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